Plasma derived exosomes: Exosomes derived from patients' plasma, centrifuged at high speeds multiple times
Study summary
Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker
Eligibility
Sex
MALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria:
\- Androgenetic Alopecia Grades 1-4
Exclusion Criteria:
* blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes
Primary outcome measure(s)
Terminal to vellus hair ratio improvement — One year Counting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.